Location History:
- München, DE (2019)
- Munich, DE (2021)
Company Filing History:
Years Active: 2019-2021
Title: Bernhard Holzmann: Innovator in Cancer Prognostics
Introduction
Bernhard Holzmann is a notable inventor based in Munich, Germany. He has made significant contributions to the field of cancer treatment, particularly focusing on colorectal cancer. With a total of 2 patents, Holzmann's work is paving the way for advancements in cancer prognosis and treatment methodologies.
Latest Patents
Holzmann's latest patents revolve around methods for treating colorectal cancer using prognostic genetic markers. These inventions relate to prognostic signatures, compositions, and methods for determining the prognosis of cancer in patients. Specifically, they utilize genetic markers to predict the prognosis of colorectal cancer based on genetic signatures. The inventions include methods for predicting the likelihood of long-term survival of cancer patients, determining treatment regimes, and preparing treatment modalities. Additionally, they encompass kits and devices designed to facilitate these methods.
Career Highlights
Holzmann is currently associated with Pacific Edge Limited, where he continues to innovate in the field of cancer research. His work is instrumental in developing new approaches to cancer treatment, enhancing the understanding of genetic factors in cancer prognosis.
Collaborations
Holzmann has collaborated with notable colleagues such as Hjalmar Nekarda and Jan Friederichs. Their combined expertise contributes to the advancement of research in cancer treatment and prognosis.
Conclusion
Bernhard Holzmann's contributions to cancer research, particularly through his innovative patents, highlight his commitment to improving patient outcomes in colorectal cancer. His work exemplifies the importance of genetic markers in predicting cancer prognosis and treatment strategies.